Eli Lilly and Company LLY will report its third-quarter 2026 earnings on Oct. 29, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $22.11 billion and $5.38 per share, respectively. Earnings estimates for 2026 have declined from $36.66 per share to $33.22 per share over the past 30 days.Zacks Investment Research Image Source: Zacks Investment Research The healthcare bellwether's performance has been solid, with the company exceeding earnings expectations in each of the trailing four quarters. It delivered a four-quarter earnings surprise of 21.25%, on average. In the last reported quarter, the company delivered a positive earnings surprise of 39.43%, as seen in the chart below.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.